mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.0077 |
0.9 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.9 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
mRNA |
leptomycin B |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |